Abstract
Overexpression of receptor tyrosine kinases including the epidermal growth factor receptor (EGF-R) as well as nonreceptor tyrosine kinases, such as Src, have been implicated in the formation of human lung cancers. In addition, cytokines like interleukin-6 (IL-6) have been demonstrated to modulate lung cancer cell growth and elevated levels of IL-6 have been shown to be an adverse prognostic factor for patients with lung cancer. Despite a large body of evidence pointing to their potential importance, few direct studies into the role of signal transducers and activators of transcription (STAT) pathways in human lung cancer have been undertaken. Here we demonstrate that multiple nonsmall cell lung cancer cell lines demonstrate constitutive Stat3 DNA-binding activity. Stat3 DNA-binding activity is specifically upregulated by the addition of epidermal growth factor (EGF), IL-6, and hepatocyte-derived growth factor (HGF). Furthermore, the stimulation of Stat3 DNA-binding activity by EGF requires the activity of EGF-R tyrosine kinase as well as Src-kinase, while the upregulation of Stat3 activity by IL-6 or HGF requires only Src-kinase activity. Treatment of A549 lung cancer cells with PD180970 or SU6656, both pharmacological inhibitors of Src-kinase, resulted in reduced Src and Stat3 activity, cell cycle arrest in G2, and reduced viability of cells accompanied by induction of apoptosis. Treatment of Stat3-positive A549 and H358 cells with antisense Stat3 oligonucleotides results in complete loss of Stat3 DNA-binding activity and apoptosis, while Stat3-positive H1299 cells remained healthy. Finally, an adenoviral vector expressing a dominant-negative Stat3 isoform results in loss of Stat3 DNA-binding activity, apoptosis, and reduced cellular viability. These results demonstrate a role of Stat3 in transducing survival signals downstream of tyrosine kinases such as Src, EGF-R, and c-Met, as well as cytokines such as IL-6, in human nonsmall cell lung cancers.
Similar content being viewed by others
References
Ankrapp DP and Bevan DR . (1993). Cancer Res., 53, 3399β3404.
Antoniades HN, Galanopoulos T, Neville-Golden J and O'Hara CJ . (1992). Proc. Natl. Acad. Sci. USA, 89, 3942β3946.
Bihl M, Tamm M, Nauck M, Wieland H, Perruchoud AP and Roth M . (1998). Am. J. Respir. Cell Mol. Biol., 19, 606β612.
Blake RA, Broome MA, Liu X, Wu J, Gishizky M, Sun L and Courtneidge SA . (2000). Mol. Cell Biol., 20, 9018β9027.
Bowman T, Garcia R, Turkson J and Jove R . (2000). Oncogene, 19, 2474β2488.
Bowman T and Jove R . (1999). Cancer Control, 6, 615β619.
Brabender J, Danenberg KD, Metzger R, Schneider PM, Park J, Salonga D, Holscher AH and Danenberg PV . (2001). Clin. Cancer Res., 7, 1850β1855.
Brognard J, Clark AS, Ni Y and Dennis PA . (2001). Cancer Res., 61, 3986β3997.
Bromberg J and Darnell Jr JE . (2000). Oncogene, 19, 2468β2473.
Bromberg JF, Horvath CM, Besser D, Lathem WW and Darnell JE . (1998). Mol. Cell Biol., 18, 2553β2558.
Bromberg JF, Wrzeszczynska MH, Devgan G, Zhao Y, Pestell RG, Albanese C and Darnell JE . (1999). Cell, 98, 295β303.
Budde RJ, Ke S and Levin VA . (1994). Cancer Biochem. Biophys., 14, 171β175.
Carbone DP . (1997). Semin. Oncol., 24, 388β401.
Catlett-Falcone R, Landowski TH, Oshiro MM, Turkson J, Levitzki A, Savino R, Ciliberto G, Moscinski L, Fernandez-Luna JL, Nunez G, Dalton WS and Jove R . (1999). Immunity, 10, 105β115.
Chaturvedi P, Reddy MV and Reddy EP . (1998). Oncogene, 16, 1749β1758.
Ciardiello F, Caputo R, Bianco R, Damiano V, Pomatico G, De Placido S, Bianco AR and Tortora G . (2000). Clin. Cancer Res., 6, 2053β2063.
Darnell Jr JE (1997). Science, 277, 1630β1635.
DeGregori J, Kowalik T and Nevins JR . (1995). Mol. Cell. Biol., 15, 4215β4224.
Doucet C, Jasmin C and Azzarone B . (2000). Oncogene, 19, 5898β5905.
Epling-Burnette PK, Liu JH, Catlett-Falcone R, Turkson J, Oshiro M, Kothapalli R, Li Y, Wang JM, Yang-Yen HF, Karras J, Jove R and Loughran Jr TP . (2001a). J. Clin. Invest., 107, 351β362.
Epling-Burnette PK, Zhong B, Bai F, Jiang K, Bailey RD, Garcia R, Jove R, Djeu JY, Loughran Jr TP and Wei S . (2001b). J. Immunol., 166, 7486β7495.
Fang K and Chen MH . (1999). Int. J. Cancer, 81, 471β478.
Favoni RE, de Cupis A, Ravera F, Cantoni C, Pirani P, Ardizzoni A, Noonan D and Biassoni R . (1994). Int. J. Cancer, 56, 858β866.
Fernandes A, Hamburger AW and Gerwin BI . (1999). Int. J. Cancer, 83, 564β570.
Fry DW . (1999). Pharmacol. Ther., 82, 207β218.
Fumagalli S, Totty NF, Hsuan JJ and Courtneidge SA . (1994). Nature, 368, 871β874.
Garcia R, Bowman TL, Niu G, Yu H, Minton S, Muro-Cacho CA, Cox CE, Falcone R, Fairclough R, Parsons S, Laudano A, Gazit A, Levitzki A, Kraker A and Jove R . (2001). Oncogene, 20, 2499β2513.
Garcia R and Jove R . (1998). J. Biomed. Sci., 5, 79β85.
Garcia R, Yu CL, Hudnall A, Catlett R, Nelson KL, Smithgall T, Fujita DJ, Ethier SP and Jove R . (1997). Cell Growth Differ., 8, 1267β1276.
Grandis JR, Drenning SD, Chakraborty A, Zhou MY, Zeng Q, Pitt AS and Tweardy DJ . (1998). J. Clin. Invest., 102, 1385β1392.
Grandis JR, Drenning SD, Zeng Q, Watkins SC, Melhem MF, Endo S, Johnson DE, Huang L, He Y and Kim JD . (2000a). Proc. Natl. Acad. Sci. USA, 97, 4227β4232.
Grandis JR, Zeng Q and Drenning SD . (2000b). Laryngoscope, 110, 868β874.
Greenlee RT, Murray T, Bolden S and Wingo PA . (2000). CA Cancer J. Clin., 50, 7β33.
Hallek M, Neumann C, Schaffer M, Danhauser-Riedl S, von Bubnoff N, de Vos G, Druker BJ, Yasukawa K, Griffin JD and Emmerich B . (1997). Exp. Hematol., 25, 1367β1377.
He TC, Zhou S, da Costa LT, Yu J, Kinzler KW and Vogelstein B . (1998). Proc. Natl. Acad. Sci. USA, 95, 2509β2514.
Hitt DC, Booth JL, Dandapani V, Pennington LR, Gimble JM and Metcalf J . (2000). Mol. Biotechnol., 14, 197β203.
Horvath CM, Wen Z and Darnell Jr JE . (1995). Genes Dev., 9, 984β994.
Hung W and Elliott B . (2001). J. Biol. Chem., 276, 12395β12403.
Ichiba M, Nakajima K, Yamanaka Y, Kiuchi N and Hirano T . (1998). J. Biol. Chem., 273, 6132β6138.
Ichimura E, Maeshima A, Nakajima T and Nakamura T . (1996). Jpn. J. Cancer Res., 87, 1063β1069.
Irby RB and Yeatman TJ . (2000). Oncogene, 19, 5636β5642.
Jiang Y, Rom WN, Yie TA, Chi CX and Tchou-Wong KM . (1999). Oncogene, 18, 6071β6077.
Jove R and Hanafusa H . (1987). Annu. Rev. Cell Biol., 3, 31β56.
Kawai T, Hiroi S and Torikata C . (1997). Lab. Invest., 77, 431β436.
Kiuchi N, Nakajima K, Ichiba M, Fukada T, Narimatsu M, Mizuno K, Hibi M and Hirano T . (1999). J. Exp. Med., 189, 63β73.
Kopantzev Y, Heller M, Swaminathan N and Rudikoff S . (2002). Oncogene, 21, 6791β6800.
Kraker AJ, Hartl BG, Amar AM, Barvian MR, Showalter HD and Moore CW . (2000). Biochem. Pharmacol., 60, 885β898.
Krystal GW, DeBerry CS, Linnekin D and Litz J . (1998). Cancer Res., 58, 4660β4666.
Krystal GW, Honsawek S, Litz J and Buchdunger E . (2000). Clin. Cancer Res., 6, 3319β3326.
Lee M, Draoui M, Zia F, Gazdar A, Oie H, Bepler G, Bellot F, Tarr C, Kris R and Moody TW . (1992). J. Natl. Cancer Inst. Monogr., 13, 117β123.
Lei W, Mayotte JE and Levitt ML . (1998). Biochem. Biophys. Res. Commun., 245, 939β945.
Lei W, Mayotte JE and Levitt ML . (1999). Anticancer Res., 19, 221β228.
Levitzki A . (1999). Pharmacol. Ther., 82, 231β239.
Ling YH, Zou Y and Perez-Soler R . (2000). Anticancer Res., 20, 693β702.
Liu J and Kern JA . (2002). Am. J. Respir. Cell Mol. Biol., 27, 306β313.
Martin F, Santolaria F, Batista N, Milena A, Gonzalez-Reimers E, Brito MJ and Oramas J . (1999). Cytokine, 11, 80β86.
Mazurenko NN, Kogan EA, Zborovskaya IB and Kisseljov FL . (1992). Eur. J. Cancer, 28, 372β377.
Moasser MM, Srethapakdi M, Sachar KS, Kraker AJ and Rosen N . (1999). Cancer Res., 59, 6145β6152.
Monia BP, Lesnik EA, Gonzalez C, Lima WF, McGee D, Guinosso CJ, Kawasaki AM, Cook PD and Freier SM . (1993). J. Biol. Chem., 268, 14514β14522.
Nevins JR, DeGregori J, Jakoi L and Leone G . (1997). Methods Enzymol., 283, 205β219.
Non-small cell lung cancer collaborative group (1995). BMJ, 311, 899β909.
Norman P . (2001). Curr. Opin. Invest. Drugs, 2, 428β434.
Odajima J, Matsumura I, Sonoyama J, Daino H, Kawasaki A, Tanaka H, Inohara N, Kitamura T, Downward J, Nakajima K, Hirano T and Kanakura Y . (2000). J. Biol. Chem. 275, 24096β24105.
Olayioye MA, Beuvink I, Horsch K, Daly JM and Hynes NE . (1999). J. Biol. Chem., 274, 17209β17218.
Olivero M, Rizzo M, Madeddu R, Casadio C, Pennacchietti S, Nicotra MR, Prat M, Maggi G, Arena N, Natali PG, Comoglio PM and Di Renzo MF . (1996). Br. J. Cancer, 74, 1862β1868.
Rabiasz GJ, Langdon SP, Bartlett JM, Crew AJ, Miller EP, Scott WN, Smyth JF and Miller WR . (1992). Br. J. Cancer, 66, 254β259.
Rahimi N, Hung W, Tremblay E, Saulnier R and Elliott B . (1998). J. Biol. Chem., 273, 33714β33721.
Reddy EP, Korapati A, Chaturvedi P and Rane S . (2000). Oncogene, 19, 2532β2547.
Roche S, Fumagalli S and Courtneidge SA . (1995). Science, 269, 1567β1569.
Rusch V, Baselga J, Cordon-Cardo C, Orazem J, Zaman M, Hoda S, McIntosh J, Kurie J and Dmitrovsky E . (1993). Cancer Res., 53, 2379β2385.
Rusch V, Klimstra D, Venkatraman E, Pisters PW, Langenfeld J and Dmitrovsky E . (1997). Clin. Cancer Res., 3, 515β522.
Schaeffer M, Schneiderbauer M, Weidler S, Tavares R, Warmuth M, de Vos G and Hallek M . (2001). Mol. Cell. Biol., 21, 8068β8081.
Shen Y, Devgan G, Darnell JE and Bromberg JF . (2001). Proc. Natl. Acad. Sci. USA, 98, 1543β1548.
Siegfried JM, Weissfeld LA, Luketich JD, Weyant RJ, Gubish CT and Landreneau RJ . (1998). Ann. Thorac. Surg., 66, 1915β1918.
Siegfried JM, Weissfeld LA, Singh-Kaw P, Weyant RJ, Testa JR and Landreneau RJ . (1997). Cancer Res., 57, 433β439.
Sirotnak FM, Zakowski MF, Miller VA, Scher HI and Kris MG . (2000). Clin. Cancer Res., 6, 4885β4892.
Song JI and Grandis JR . (2000). Oncogene, 19, 2489β2495.
Takahashi T, Fukuda K, Pan J, Kodama H, Sano M, Makino S, Kato T, Manabe T and Ogawa S . (1999). Circ Res., 85, 884β891.
Takanami I, Imamura T, Yamamoto Y and Kodaira S . (1995). J. Surg. Oncol., 58, 40β43.
Taylor SJ and Shalloway D . (1994). Nature, 368, 867β871.
Tice DA, Biscardi JS, Nickles AL and Parsons SJ . (1999). Proc. Natl. Acad. Sci. USA, 96, 1415β1420.
Tsao MS, Liu N, Chen JR, Pappas J, Ho J, To C, Viallet J, Park M and Zhu H . (1998). Lung Cancer, 20, 1β16.
Turkson J, Bowman T, Garcia R, Caldenhoven E, De Groot RP and Jove R . (1998). Mol. Cell Biol., 18, 2545β2552.
Wang WL, Healy ME, Sattler M, Verma S, Lin J, Maulik G, Stiles CD, Griffin JD, Johnson BE and Salgia R . (2000a). Oncogene, 19, 3521β3528.
Wang YZ, Wharton W, Garcia R, Kraker A, Jove R and Pledger WJ . (2000b). Oncogene, 19, 2075β2085.
Yanagawa H, Sone S, Takahashi Y, Haku T, Yano S, Shinohara T and Ogura T . (1995). Br. J. Cancer, 71, 1095β1098.
Yu CL, Meyer DJ, Campbell GS, Larner AC, Carter-Su C, Schwartz J and Jove R . (1995). Science, 269, 81β83.
Zhang YW, Wang LM, Jove R and Vande Woude GF . (2002). Oncogene, 21, 217β226.
Zhong Z, Wen Z and Darnell Jr JE . (1994). Science, 264, 95β98.
Zong CS, Chan J, Levy DE, Horvath C, Sadowski HB and Wang LH . (2000). J. Biol. Chem., 275, 15099β15105.
Acknowledgements
We thank members of the Jove lab for stimulating discussions and help with experiments, Dr Doug Cress for advice, Dr Gerold Bepler for providing cell lines, Rebecca Alexander for administrative assistance, Dr Martin Broome at SUGEN for providing SU6656, and the Moffitt Cancer Center Flow Cytometry and Molecular Imaging Core Facilities. This work was partially funded by the Chiles Endowment Biomedical Research Program of the Florida Department of Health (EBH) and by NIH grant CA82533 (RJ).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Song, L., Turkson, J., Karras, J. et al. Activation of Stat3 by receptor tyrosine kinases and cytokines regulates survival in human non-small cell carcinoma cells. Oncogene 22, 4150β4165 (2003). https://doi.org/10.1038/sj.onc.1206479
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1206479
- Springer Nature Limited
Keywords
This article is cited by
-
5-Methoxytryptophan enhances the sensitivity of sorafenib on the inhibition of proliferation and metastasis for lung cancer cells
BMC Cancer (2024)
-
Effect of plant produced Anti-hIL-6 receptor antibody blockade on pSTAT3 expression in human peripheral blood mononuclear cells
Scientific Reports (2023)
-
Interplay between signal transducers and activators of transcription (STAT) proteins and cancer: involvement, therapeutic and prognostic perspective
Clinical and Experimental Medicine (2023)
-
Nintedanib induces senolytic effect via STAT3 inhibition
Cell Death & Disease (2022)
-
Oncogenic dependency on STAT3 serine phosphorylation in KRAS mutant lung cancer
Oncogene (2022)